Workflow
Graphic Packaging to Present at Wells Fargo Industrials and Materials Conference on June 11
Prnewswire· 2025-06-05 11:30
ATLANTA, June 5, 2025 /PRNewswire/ -- Graphic Packaging Holding Company (NYSE: GPK) ("Graphic Packaging"), a global leader in sustainable consumer packaging, today announced that Stephen R. Scherger, Executive Vice President and Chief Financial Officer, will present at the Wells Fargo Industrials and Materials Conference on Wednesday, June 11th at 3:15pm ET.The presentation will be available live and in replay via webcast. The archived webcast can be accessed from the Graphic Packaging website at https://in ...
Generac Promotes Jim Barnes to Executive Vice President - Global Supply Chain
Prnewswire· 2025-06-05 11:30
WAUKESHA, Wis., June 5, 2025 /PRNewswire/ -- Generac Holdings Inc. (NYSE: GNRC), a leading global designer, manufacturer and provider of energy technology solutions and other power products, today announced the promotion of Jim Barnes to Executive Vice President – Global Supply Chain. Barnes's promotion follows the planned retirement of Roger Pascavis, who will step down on June 27, 2025, after a distinguished 30-year career with Generac. Pascavis joined the company in 1995 and has since held a series of pr ...
Dyne Therapeutics to Present New Preclinical Data in Facioscapulohumeral Muscular Dystrophy at the FSHD Society International Research Congress
GlobeNewswire News Room· 2025-06-05 11:30
- DYNE-302 Demonstrated Functional Improvement in an FSHD Preclinical Model - WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases, today announced that it will be presenting new preclinical data demonstrating the potential of DYNE-302 to achieve functional improvement in facioscapulohumeral muscular dystrophy (FSHD). The data will ...
Colliers completes acquisition of Triovest
Globenewswire· 2025-06-05 11:30
TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today it has completed its previously announced acquisition of Triovest Inc. (“Triovest”), a leading Canadian commercial real estate services platform. The acquisition solidifies Colliers’ position as Canada’s largest commercial real estate services firm, employing more than 3,000 professionals, managing more than 95 million square feet of commercial ...
Cellebrite to Acquire Corellium
Globenewswire· 2025-06-05 11:30
Core Viewpoint - Cellebrite has announced its agreement to acquire Corellium for an enterprise value of $170 million in cash, enhancing its capabilities in digital investigations and security for smart devices [2][3] Company Overview - Cellebrite is a global leader in digital investigative solutions, focusing on enhancing digital investigations and intelligence gathering to accelerate justice [6] - Corellium specializes in Arm hypervisor virtualization, providing solutions for security and developer teams to build, test, and secure software for mobile, automotive, and IoT devices [7] Acquisition Details - The acquisition is valued at $170 million, with $20 million converted to equity at closing, and an additional $30 million contingent on performance milestones over the next two years [2] - The deal is expected to close in summer 2025, pending approval from the Committee on Foreign Investment in the United States [2] Strategic Benefits - The combination of Cellebrite and Corellium is expected to set a new standard for digital investigations and enhance the security of Arm-based devices across various applications [1] - Corellium's technology will broaden Cellebrite's Total Addressable Market (TAM) in both public and private sectors, enhancing its Digital Investigation Platform and mobile vulnerability research capabilities [1][2] Technological Advancements - The acquisition will enable accelerated identification of mobile vulnerabilities and exploits, and provide an industry-first ability to visualize and interact with virtual devices [4] - Corellium's virtualization platform will enhance DevSecOps efficiency across all Arm-based devices, facilitating the development of high-performance, secure mobile applications and IoT devices [4][1]
Bread Financial Announces Early Tender Results of Its Previously Announced Cash Tender Offer
Globenewswire· 2025-06-05 11:30
Core Points - Bread Financial Holdings, Inc. announced a cash tender offer for its 9.750% Senior Notes due 2029, with approximately $536,786,000 validly tendered by the Early Participation Date [1][3] - The company plans to accept up to $150,000,000 in aggregate principal amount of the Notes, resulting in a Total Consideration of $1,071.25 for each $1,000 principal amount of Notes accepted [1][5] - The Tender Offer includes an early participation amount of $50.00 per $1,000 principal amount of Notes for those who tendered by the Early Participation Date [3][5] Tender Offer Details - The total outstanding principal amount of the 9.750% Senior Notes is $900,000,000, with $536,786,000 tendered as of the Early Participation Date [2] - The expected total consideration for the accepted Notes includes the early participation amount and accrued interest [3][5] - The company anticipates settlement of the accepted Notes on June 9, 2025, subject to the conditions set forth in the Offer to Purchase [7] Proration and Acceptance - Due to the Tender Cap being exceeded, the company will accept Notes on a prorated basis, with an expected proration factor of approximately 77.538% for those tendered at the Clearing Premium [7] - Notes tendered at a Bid Price resulting in a Bid Premium exceeding the Clearing Premium will not be accepted [7] Dealer Managers - J.P. Morgan Securities LLC is the sole lead dealer manager for the tender offer, with several co-dealer managers assisting in the process [8]
Bowman to Ring Nasdaq Opening Bell in Honor of 30th Anniversary
Globenewswire· 2025-06-05 11:30
Event Recognizes Bowman’s Journey from Local Firm to National Engineering PartnerRESTON, Va., June 05, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, will ring the Nasdaq Stock Market opening bell on June 9, 2025, commemorating its 30th anniversary. Founder and CEO, Gary Bowman, alongside members of the Company’s leadership team and employees, will participate in the ceremonial bell ringing at the Nasdaq MarketSite in Times ...
Ballard Power announces results of 2025 Annual General Meeting of Shareholders
Prnewswire· 2025-06-05 11:30
About Ballard Power Systems All nominees listed in the Management Proxy Circular dated April 7th, 2025 were elected as directors of the Company. Each of the Ballard directors was re-elected by a majority of the votes cast by shareholders present or represented by proxy. Director biographies are available in the "Our Leadership" section of the Company's website. | Director Nominee | Votes For | % For | Votes Withheld | % Withheld | | --- | --- | --- | --- | --- | | Kathy Bayless | 84,684,573 | 97.71 | 1,988, ...
Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway
Prnewswire· 2025-06-05 11:30
VANCOUVER, BC, June 5, 2025 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today announced the signing of a new supply agreement with California-based rail operator Sierra Northern Railway (https://www.sierranorthern.com) for the supply of 1.5 MW of fuel cell engines, expected to be delivered in 2025. As part of Sierra Northern Railway's efforts to decarbonize its operations across California, 12 Ballard FCmove®-XD engines will be supplied to convert three diesel switching locomotives to hy ...
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
GlobeNewswire News Room· 2025-06-05 11:30
DUBLIN, June 05, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that LUMRYZTM has been granted Orphan Drug Designation (ODD) from the U.S. Food & Drug Administration (FDA) for the treatment of Idiopathic Hypersomnia (IH). Specifically, ODD was granted based on the plausible hypothesis that LUMRYZ may be clinically superior to the same drug(s) already approved for the same indication, becaus ...